MarketWatch

Roche files to use Pegasys drug to treat hepatitis B

LONDON (CBS.MW) -- Swiss drugmaker Roche on Wednesday said it has filed with the U.S. Food and Drug Administration and the European Medicines Agency to market Pegasys for the treatment of chronic ...
BioWorld

Roche Gains U.S. Approval Of Pegasys For Treating Hepatitis C

Hoffmann-La Roche Inc. received FDA clearance to sell Pegasys, a pegylated interferon for the treatment of hepatitis C, making it the second drug on the market for this disease developed using ...
Houston Chronicle

U.S. FDA approves Roche hepatitis C drug

WASHINGTON - The U.S. Food and Drug Administration said today it had approved Roche Holding AG's Pegasys drug in combination with another anti-viral compound to treat hepatitis C, a potential ...
MarketWatch

Roche Pharma wins EU approval for Pegasys Hep B drug

LONDON (MarketWatch) -- Switzerland's Roche Pharmaceuticals said the Commission of the European Union has approved its Pegasys drug for the treatment of chronic hepatitis B. "The approval means that ...
Los Angeles Times

Study Finds Better Combination of Drugs for Treating Hepatitis C

ICN Pharmaceutical Inc.’s prize drug ribavirin works better with a new Roche Holding product in treating hepatitis C than it does with its current drug combination to treat the liver disease, ...
Reuters

Schering says hepatitis drug matches Roche drug

NEW YORK (Reuters) - The world's leading treatments for hepatitis C were similarly effective in the first large trial pitting them against each other, Schering-Plough Corp said on Monday. Sign up here ...
Los Angeles Times

Study Finds Better Drug Partner for ICN’s Hepatitis C Treatment

ICN Pharmaceutical Inc.’s prize drug ribavirin works better with a new Roche Holding product in treating hepatitis C than it does with its current drug combination to treat the liver disease, ...